Setting up a pharmaceutical manufacturing plant is a complex, multi-year project that involves strategic planning, regulatory compliance, facility design, equipment procurement, process validation, and quality system implementation — all before a single commercial batch can be manufactured. This comprehensive guide walks you through the complete plant setup journey — from initial planning and dosage form selection through facility design, equipment specification, GMP compliance, regulatory approvals, and commercial launch readiness — with a complete equipment checklist for every major pharmaceutical manufacturing category.
Whether you are setting up your first pharmaceutical manufacturing facility, expanding an existing plant with a new dosage form, or planning a greenfield pharmaceutical factory, this guide will help you structure your project effectively and ensure every critical element is covered.
Before any facility or equipment decisions are made, the strategic foundation must be established. Define your target dosage forms (tablets, capsules, oral liquids, injectables, semi-solids, API), target markets (domestic India, regulated export — US/EU/WHO, semi-regulated export — Africa/Southeast Asia), planned capacity and annual production volume, product portfolio, and investment budget. The dosage form and target market determine every subsequent decision — from facility classification and area requirements to equipment selection and regulatory filing strategy.
A pharmaceutical manufacturing licence in India (Drug Manufacturing Licence under Form 25 / Form 28 of the Drugs and Cosmetics Act, 1940) is mandatory before any manufacturing can begin. For export to regulated markets, additional WHO GMP certification, US FDA registration (Drug Establishment Registration), or EU GMP approval are required. The regulatory strategy — particularly the scope of products and dosage forms to be licensed — must be finalised before facility design begins, because different licences require different facility configurations, area sizes, and equipment sets per Schedule M.
Site selection must balance regulatory requirements (pharmaceutical zone classification, pollution board permissions, proximity to utilities), logistics (raw material supply, distribution access), and commercial factors (labour availability, land cost). Facility design must be prepared by a pharma-specialised architect / engineering consultant — covering cleanroom classifications, HVAC design (air change rates, pressure differentials, temperature/humidity control), personnel and material flow, process equipment layout, utility room design (compressed air, purified water, steam, chilled water, electrical supply), and environmental monitoring infrastructure. A fundamental design principle is that pharmaceutical manufacturing areas must be designed around the equipment and process flow — not the other way round.
Equipment procurement for a new pharmaceutical plant is typically the longest-lead-time activity in the project — from URS (User Requirements Specification) preparation and supplier evaluation through order placement, fabrication, factory acceptance testing, and delivery. Equipment lead times for custom GMP pharmaceutical equipment in India typically range from 8 to 20 weeks depending on complexity. Equipment procurement should be initiated as early as possible — ideally in parallel with facility construction — to avoid delays to project commissioning timelines.
After equipment delivery and installation, the qualification programme (IQ, OQ, PQ) must be executed for all critical manufacturing equipment, utilities, HVAC systems, and water systems. Process validation (minimum 3 consecutive batches at commercial scale meeting all specifications) must be completed before commercial production can begin. Cleaning validation, analytical method validation, and computer system validation (for automated systems) are also required. The qualification and validation phase is typically 6–12 months for a new facility — depending on the number of dosage forms, products, and equipment items to be qualified.
Once the facility is complete, qualified, and all validation activities are done, the CDSCO / State Drug Authority conducts a GMP inspection of the facility. The inspection covers facility design and construction, equipment qualification, water system validation, HVAC qualification, quality management systems, batch manufacturing records, standard operating procedures, and personnel training records. Upon satisfactory inspection, the Drug Manufacturing Licence is issued. For WHO GMP or US FDA regulated market access, additional inspections by those agencies or their authorised inspectorates are required.
With the manufacturing licence in hand, the first commercial batches can be manufactured, tested, and released. Commercial launch requires approved product dossiers (marketing authorisations / product licences), validated batch manufacturing records, trained manufacturing and quality personnel, qualified QC laboratory with validated analytical methods, approved raw material suppliers, approved packaging suppliers, and a functional pharmacovigilance system for post-market safety monitoring.
The dosage forms you plan to manufacture determine the exact equipment configuration required. Use this table to identify your equipment needs based on your planned product portfolio:
| Target Dosage Form | Primary Equipment Required | GMP Area Classification |
|---|---|---|
| Tablets (wet granulation) | RMG, FBD, Multi Mill, Vibro Sifter, Blender, IPC Bin, Tablet Press, Coating Pan | Controlled environment; temp 20–25°C; RH 40–60% |
| Tablets (direct compression) | Vibro Sifter, Blender, IPC Bin, Tablet Press, Coating Pan | Controlled environment; temp 20–25°C; RH 40–60% |
| Hard gelatin capsules | Vibro Sifter, Blender, IPC Bin, Capsule Filling Machine | Controlled environment; RH 40–60% |
| Oral liquid syrups / solutions | Syrup Plant, Sparkler Filter Press, Zero Hold Up Filter Press, Filling Machine | Grade D (oral liquid area); temp 20–25°C |
| Creams, ointments, gels | Cream & Lotion System, Colloid Mill, Paste Kettle, Tube/Jar Filling Machine | Grade D (semi-solid area); temp 20–25°C |
| API (chemical synthesis) | SS Reactor, Condenser, Receiver, ANFD, VTD | Chemical processing area; ATEX-classified |
| Sterile injectables (aseptic) | MCD Plant (WFI), Sterile Mfg Vessel, Zero Hold Up Filter Press, Filling Machine (RABS/Isolator) | Grade A/B/C/D classified cleanrooms |
Tablet Plant — Core Equipment Checklist
Oral Liquid Plant — Core Equipment Checklist
Cream & Lotion Plant — Core Equipment Checklist
API / Chemical Plant — Core Equipment Checklist
Sterile Injectable Plant — Core Equipment Checklist
| Dosage Form | Minimum Dedicated Areas Required | Air Handling | Water Quality |
|---|---|---|---|
| Tablets / Capsules | Dispensing, granulation, drying, blending, compression, coating, packaging, QC lab, stores | Temperature (20–25°C), humidity (40–60% RH), pressure differential between areas | Purified Water for equipment cleaning; potable water for other uses |
| Oral Liquids | Dispensing, manufacturing, filtration, filling, packaging, QC lab, stores | Grade D controlled environment; temp 20–25°C; positive pressure | Purified Water (IP/USP specification) at point of use |
| Creams / Ointments | Dispensing, manufacturing (with HVAC), filling, packaging, QC, stores | Grade D; temp 20–25°C; humidity control (for stability) | Purified Water for manufacturing and cleaning |
| API (chemical synthesis) | Synthesis area (ATEX-classified), ANFD area, drying area, testing lab, solvent storage | Solvent vapour extraction; ATEX Zone 1/2 electrical classification; LEV systems | Purified Water for final API washing; DM water for process use |
| Sterile Injectables | Grade A/B/C/D cleanrooms; WFI generation; clean steam; filling suite; autoclave; inspection | HEPA-filtered; defined air change rates per grade; differential pressure monitoring; continuous EM | WFI (IP/BP/USP) for all product-contact operations and equipment rinsing |
Standard Utility Requirements for a Pharmaceutical Plant
| Approval / Licence | Issuing Authority | Typical Timeline | Requirement |
|---|---|---|---|
| Drug Manufacturing Licence (Form 25 / Form 28) | State Drug Authority (SDA) / CDSCO | 6–18 months from application | Mandatory for all pharma manufacturing in India |
| WHO GMP Certificate | WHO / CDSCO (National GMP Certification Scheme) | 12–24 months post licence | Required for exports to WHO-prequalified markets (Africa, Southeast Asia) |
| US FDA Registration (DUNS / Drug Establishment) | US FDA | Online registration; site inspection within 2 years | Required for US export; facility must be FDA-inspected before product approval |
| EU GMP Certification | EU National Competent Authorities (EMA network) | 12–24 months; depends on inspection slot availability | Required for export to EU member states |
| Factory Licence (Factories Act) | State Labour Department | 2–4 months | Mandatory for all manufacturing establishments in India |
| Pollution Control Consent (CTE/CTO) | State Pollution Control Board | 3–6 months | Mandatory; pharmaceutical plants are classified as "Red" category |
| Fire NOC | State Fire Department | 2–4 months | Mandatory; particularly important for solvent-handling API and coating plants |
Setting up a pharmaceutical manufacturing plant is a major, multi-year undertaking — but with the right strategic planning, facility design, equipment selection, and regulatory approach, it is an eminently achievable project that creates a long-term commercial asset serving your business for decades. The equipment checklists in this guide provide a solid starting framework for each dosage form — adapt them to your specific product portfolio, batch sizes, and regulatory market requirements.
As a full-range GMP pharmaceutical equipment manufacturer, supplier, and exporter, we are uniquely positioned to supply the complete equipment range for your new pharmaceutical plant — regardless of the dosage form. From Rapid Mixer Granulators and Fluid Bed Dryers for tablet plants, to Syrup Manufacturing Plants and Sparkler Filter Presses for oral liquid plants, to SS Reactors and ANFDs for API plants, to Multi Column Distillation Plants and Sterile Manufacturing Vessels for injectable facilities — we supply it all, with complete GMP documentation, FAT, and full after-sales support.
Speak with our technical team for expert guidance on equipment selection, capacity planning, and complete plant configuration for your new facility.
Send Enquiry Contact UsNeed pharmaceutical equipment? Get a free quotation & technical consultation.
Send Enquiry Call: +91 88791 92449Bipin Pharma Equipment manufactures GMP-compliant pharmaceutical machinery, exported to 25+ countries. Contact us for expert advice and a competitive quote.
Request a Free Quote Call: +91 88791 92449